China Biologic Products, Inc. (NASDAQ:CBPO) is a biopharmaceutical company. The Company through our indirect majority-owned People’s Republic of China subsidiaries, Shandong Taibang Biological Products Co. Ltd. (Shandong Taibang) and Guizhou Taibang Biological Products Co., Ltd. (Guizhou Taibang), and its minority-owned People’s Republic of China investee, Xi’an Huitian Blood Products Co., Ltd (Huitian), principally engaged in the research, development, manufacturing and sales of human plasma-based pharmaceutical products in China.
China Biologic Products Inc
新闻
CCG投资者关系公司,一家总部位于美国的全球投资者关系和战略传播咨询机构,于今天宣布2013年中国最佳投资会议的会议发言公司名单。本次会议将集中展示中国最优秀的海外上市公司,积极建立其与全球投资者的对话。会议由麦楷博平会计师事务所联合主办。麦楷博平会计师事务所是一家美国顶尖的会计咨询公司,在中国有丰富的实践经验。
###
43,199 公司背景浏览
- 本页浏览人次: (过去7日: 12) (过去30日: 43) (自发布以来: 9650)